Literature DB >> 9661040

Bactericidal activities of ceftizoxime and cefotaxime against Streptococcus pneumoniae.

K B Waites, T Rivers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661040      PMCID: PMC105702     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  6 in total

1.  Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.

Authors:  J Liñares; T Alonso; J L Pérez; J Ayats; M A Domínguez; R Pallarés; R Martín
Journal:  J Antimicrob Chemother       Date:  1992-09       Impact factor: 5.790

2.  Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics.

Authors:  J S Bradley; J D Connor
Journal:  Pediatr Infect Dis J       Date:  1991-11       Impact factor: 2.129

Review 3.  Management of antibiotic-resistant pneumococcal infections.

Authors:  K P Klugman
Journal:  J Antimicrob Chemother       Date:  1994-08       Impact factor: 5.790

4.  Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae.

Authors:  K B Patel; D P Nicolau; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

5.  Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.

Authors:  D W Haas; C W Stratton; J P Griffin; L Weeks; S C Alls
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

6.  In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.

Authors:  C W Stratton; K E Aldridge; M S Gelfand
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.